These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 24390518)

  • 1. Clinical and radiological observations in a case series of 26 patients with fibrous dysplasia.
    Thomsen MD; Rejnmark L
    Calcif Tissue Int; 2014 Apr; 94(4):384-95. PubMed ID: 24390518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of Long-Term Bisphosphonate Therapy in McCune-Albright Syndrome and Polyostotic Fibrous Dysplasia.
    Majoor BC; Appelman-Dijkstra NM; Fiocco M; van de Sande MA; Dijkstra PS; Hamdy NA
    J Bone Miner Res; 2017 Feb; 32(2):264-276. PubMed ID: 27649526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fracture incidence in polyostotic fibrous dysplasia and the McCune-Albright syndrome.
    Leet AI; Chebli C; Kushner H; Chen CC; Kelly MH; Brillante BA; Robey PG; Bianco P; Wientroub S; Collins MT
    J Bone Miner Res; 2004 Apr; 19(4):571-7. PubMed ID: 15005844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrous dysplasia & McCune-Albright syndrome: an experience from a tertiary care centre in north India.
    Bhadada SK; Bhansali A; Das S; Singh R; Sen R; Agarwal A; Mittal BR; Nahar U; Dutta P; Khandelwal N
    Indian J Med Res; 2011 May; 133(5):504-9. PubMed ID: 21623035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyostotic Fibrous Dysplasia With and Without McCune-Albright Syndrome-Clinical Features in a Nordic Pediatric Cohort.
    Utriainen P; Valta H; Björnsdottir S; Mäkitie O; Horemuzova E
    Front Endocrinol (Lausanne); 2018; 9():96. PubMed ID: 29599748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EFFICACY AND SAFETY OF BISPHOSPHONATE THERAPY IN MCCUNE-ALBRIGHT SYNDROME-RELATED POLYOSTOTIC FIBROUS DYSPLASIA: A SINGLE-CENTER EXPERIENCE.
    Wang Y; Wang O; Jiang Y; Li M; Xia W; Meng X; Xing X
    Endocr Pract; 2019 Jan; 25(1):23-30. PubMed ID: 30383490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic journey for individuals with fibrous dysplasia / McCune albright syndrome (FD/MAS).
    Song K; Shrestha R; Delaney H; Vijjhalwar R; Turner A; Sanchez M; Javaid MK
    Orphanet J Rare Dis; 2024 Feb; 19(1):50. PubMed ID: 38326833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lesion Expansion in Gnathic Fibrous Dysplasia: Natural History, Indicators of Progression, and Response to Bisphosphonates.
    Pan KS; Taylor J; Szymczuk V; Boyce AM
    J Bone Miner Res; 2023 Oct; 38(10):1465-1471. PubMed ID: 37477421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological Interventions Targeting Pain in Fibrous Dysplasia/McCune-Albright Syndrome.
    Tucker-Bartley A; Selen DJ; Golden E; van Gool R; Ebb D; Mannstadt M; Upadhyay J
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. McCune-Albright syndrome.
    Dumitrescu CE; Collins MT
    Orphanet J Rare Dis; 2008 May; 3():12. PubMed ID: 18489744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Factors From an Epidemiologic Evaluation of Fibrous Dysplasia of Bone in a Modern Cohort: The FRANCEDYS Study.
    Benhamou J; Gensburger D; Messiaen C; Chapurlat R
    J Bone Miner Res; 2016 Dec; 31(12):2167-2172. PubMed ID: 27340799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of polyostotic fibrous dysplasia].
    Klempous J; Kuźniar J; Sztuka A; Jaworska M
    Wiad Lek; 2006; 59(1-2):125-7. PubMed ID: 16646308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. McCune-Albright syndrome onset with vaginal bleeding.
    Van Doan N; Minh Duc N; Kim Ngan V; Van Anh N
    BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34281944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difficulties in diagnosis and treatment of acromegaly in a patient with a McCune-Albright syndrome. A case report and a review of literature.
    Baszko-Błaszyk D; Slynko J; Liebert W; Sosnowski P; Sowiński J; Waśko R
    Neuro Endocrinol Lett; 2010; 31(5):594-6. PubMed ID: 21173751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extent of Extraskeletal Manifestations of Fibrous Dysplasia/McCune-Albright Syndrome in Patients with Mazabraud's Syndrome.
    Hagelstein-Rotman M; Appelman-Dijkstra NM; Boyce AM; Chapurlat R; Dur NBJ; Gensburger D; Majoor BCJ; van de Sande MAJ; Dijkstra PDS
    Calcif Tissue Int; 2022 Mar; 110(3):334-340. PubMed ID: 34854944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early fractures and occult hyperthyroidism: McCune-Albright syndrome?
    Di Candia S; Weber G; Mora S; de Pellegrin M; Chiumello G
    Horm Res; 2001; 56(1-2):58-62. PubMed ID: 11815729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathological analysis of 105 patients with fibrous dysplasia of cranio-maxillofacial region].
    Xue J; Zhang JY; Shi RR; Xie XY; Bai JY; Li TJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 54(1):54-61. PubMed ID: 35165468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrous dysplasia of bone: craniofacial and dental implications.
    Burke AB; Collins MT; Boyce AM
    Oral Dis; 2017 Sep; 23(6):697-708. PubMed ID: 27493082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrous dysplasia of bone and McCune-Albright syndrome.
    Chapurlat RD; Orcel P
    Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):55-69. PubMed ID: 18328981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Odontoiatric perspectives and osteonecrosis of the jaw as a possible adverse effect of bisphosphonates therapy in fibrous dysplasia and McCune-Albright syndrome.
    Tessaris D; Matarazzo P; Lala R; Defabianis P
    J Pediatr Endocrinol Metab; 2016 Mar; 29(3):333-6. PubMed ID: 26565547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.